Suchergebnisse - "Ge, Weiyu"

PubPharm (21)

1

Activation of the PI3K/AKT signaling pathway by ARNTL2 enhances cellular glycolysis and sensitizes pancreatic adenocarcinoma to erlotinib

enthalten in: Molecular cancer | 2024

von Ge, W. | Wang, Y. | Quan, M. | +12

2

Activation of the PI3K/AKT signaling pathway by ARNTL2 enhances cellular glycolysis and sensitizes pancreatic adenocarcinoma to erlotinib

enthalten in: Molecular cancer | 2024

von Ge, W. | Wang, Y. | Quan, M. | +12

3

Cuproptosis-related lncRNAs are correlated with tumour metabolism and immune microenvironment and predict prognosis in pancreatic cancer patients

enthalten in: IET systems biology | 2023

von Wang, Y. | Ge, W. | Xue, S. | +9

4

Chemotherapeutic drugs-induced pyroptosis mediated by gasdermin E promotes the progression and chemoresistance of pancreatic cancer

enthalten in: Cancer letters | 2023

von Li, S. | Yue, M. | Xu, H. | +11

5

PLA2G2A+ cancer-associated fibroblasts mediate pancreatic cancer immune escape via impeding antitumor immune response of CD8+ cytotoxic T cells

enthalten in: Cancer letters | 2023

von Ge, W. | Yue, M. | Lin, R. | +14

6

A Novel Molecular Signature of Cancer-Associated Fibroblasts Predicts Prognosis and Immunotherapy Response in Pancreatic Cancer

enthalten in: International journal of molecular sciences | 2022

von Ge, W. | Yue, M. | Wang, Y. | +10

7

HDACs/mTOR inhibitor synergizes with pyrotinib in HER2-positive pancreatic cancer through degradation of mutant P53

enthalten in: Cancer cell international | 2022

von Mao, T. | Zhang, X. | Xu, H. | +8

8

HDACs/mTOR inhibitor synergizes with pyrotinib in HER2-positive pancreatic cancer through degradation of mutant P53

enthalten in: Cancer cell international | 2022

von Mao, T. | Zhang, X. | Xu, H. | +8

9

Cuproptosis-related lncRNAs are correlated with metabolism and immune microenvironment and predict prognosis in pancreatic cancer patients

enthalten in: ResearchSquare.com | 2022

von Wang, Y. | Ge, W. | Xue, S. | +4

10

Synergistic blocking of RAS downstream signaling and epigenetic pathway in KRAS mutant pancreatic cancer

enthalten in: Aging | 2022

von Zhang, X. | Mao, T. | Xu, H. | +10